IBIO
iBio, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$91.41M
P/E Ratio
—
EPS
$-0.56
Beta
1.24
52W High
$3.82
52W Low
$0.56
50-Day MA
$1.89
200-Day MA
$1.63
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About iBio, Inc. Common Stock
iBio, Inc., a biotech company, provides contract development and manufacturing services to outside partners and customers in the United States. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | 300,000 |
| Gross Profit (TTM) | 300,000 |
| EBITDA | $-28.27M |
| Operating Margin | -9653.00% |
| Return on Equity | -62.10% |
| Return on Assets | -34.50% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.25 |
| Price-to-Book | 1.18 |
| Price-to-Sales (TTM) | 304.70 |
| EV/Revenue | 63.12 |
| EV/EBITDA | -1.59 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 14.30% |
| Shares Outstanding | $49.68M |
| Float | $39.32M |
| % Insiders | 1.71% |
| % Institutions | 46.88% |
Historical Volatility
HV 10-Day
103.29%
HV 20-Day
91.64%
HV 30-Day
81.95%
HV 60-Day
90.61%
HV Rank
15.9%
Volatility is currently expanding
Analyst Ratings
Consensus ($5.53 target)
6
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026